Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Oct 09, 2019

SELL
$62.51 - $69.0 $1.06 Million - $1.17 Million
-17,000 Closed
0 $0
Q2 2019

Jul 17, 2019

SELL
$61.87 - $69.38 $30,935 - $34,690
-500 Reduced 2.86%
17,000 $1.15 Million
Q1 2019

Apr 04, 2019

BUY
$62.53 - $70.05 $43,771 - $49,035
700 Added 4.17%
17,500 $1.14 Million
Q4 2018

Jan 15, 2019

BUY
$60.54 - $79.0 $48,432 - $63,200
800 Added 5.0%
16,800 $1.05 Million
Q3 2018

Oct 15, 2018

SELL
$71.28 - $78.92 $64,152 - $71,028
-900 Reduced 5.33%
16,000 $1.24 Million
Q2 2018

Jul 10, 2018

BUY
$64.88 - $75.68 $103,808 - $121,088
1,600 Added 10.46%
16,900 $1.2 Million
Q1 2018

Apr 13, 2018

SELL
$72.84 - $88.8 $152,964 - $186,480
-2,100 Reduced 12.07%
15,300 $1.15 Million
Q3 2017

Oct 10, 2017

BUY
$72.11 - $85.47 $1.25 Million - $1.49 Million
17,400
17,400 $1.41 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Polianta LTD Portfolio

Follow Polianta LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polianta LTD, based on Form 13F filings with the SEC.

News

Stay updated on Polianta LTD with notifications on news.